Morepen Labs names Kushal Suri as President - International Growth
Baddi: Morepen Labs has announced the redesignation of Senior Management Personnel, Kushal Suri, as President - International Growth. He previously held the position of Director – API Sales & Marketing.
The company disclosed the leadership change in a regulatory filing with the BSE, stating, "We wish to inform you that the designation of Mr. Kushal Suri, Senior Management Personnel, has been changed from "Director – API Sales & Marketing" to "President – International Growth," with effect from April 28, 2025.".
Kushal Suri holds an M.B.A. degree from Regent’s University, London (UK), with a major in Marketing and a minor in Consultancy, along with various other accolades from Harvard University, Cambridge (USA). In the past, he has worked with international organizations such as Houlihan Lokey, Singapore. Kushal Suri is the nephew of Sushil Suri, Chairman & Managing Director, and Sanjay Suri, Whole-Time Director of the Company.
Read also: Morepen Labs receives anti-allergy API Loratadine approval for export to China
Morepen Laboratories Ltd. is an Indian pharmaceutical company with a global footprint across 82 countries. All APIs are manufactured in-house at USFDA-approved facilities.
Next Story